BioScience News and Advocate Daily Highlights 9/2
Daily Highlights
1. No evidence bird flu passed from
humans, WHO says
2. Leftover embryos could benefit
research
3. Heart-healthy meat may be on the menu
4.
Greenpeace challenges Monsanto patent
5. Balancing risks
and benefits - Spiked online debate
6. Big pharma calls
on small biotech firm
No evidence bird flu passed
from humans, WHO says
Genetic evidence shows bird flu is
not being passed from person to person in Vietnam,
reassuring news that suggests the outbreaks that have killed
18 people have not become an epidemic, the World
Heal...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6128
Leftover
embryos could benefit research
It should be legal for
leftover embryos from fertility treatments to be used for
stem cell research, according to a keynote speaker at this
week's New Zealand Bioethics Conference. Gareth Jones,
p...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6126
Heart-healthy
meat may be on the menu
Fish oils known to help prevent
heart attacks can now be made by land animals for
themselves, thanks to work by genetic engineers. The
researchers inserted a gene from a nematode worm into mice
wh...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6124
Greenpeace
challenges Monsanto patent
Greenpeace is challenging
patent rights to a wheat strain granted to Monsanto, the
world's largest genetically modified (GM) seed company, on
grounds of "biopiracy." The dispute continues the
environm...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6123
Balancing
risks and benefits - Spiked online debate
Continuing the
Spiked online debate, Dr Gill Samuels of Pfizer writes about
balancing the risks and benefits of research.In areas where
new science and technologies are being employed, an
e...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6120
Big
pharma calls on small biotech firm
Three of the world's
largest drug makers, Bristol-Myers Squibb, Abbott
Laboratories and Eli Lilly, are turning to a tiny Silicon
Valley company to help them develop drugs. Troy May writes
in the S...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6118
From
the BioScience News Team
BioScience Communications
Limited
Editor: Christine
Ross